Discounted Drugs for Needy Patients and Hospitals - Understanding the 340B Debate

N Engl J Med. 2018 Feb 8;378(6):501-503. doi: 10.1056/NEJMp1716139. Epub 2018 Jan 24.

Authors

Walid F Gellad¹, A Everette James¹

Affiliation

¹ From the Division of General Medicine and the Center for Pharmaceutical Policy and Prescribing (W.F.G.) and the Health Policy Institute and Department of Health Policy and Management, Graduate School of Public Health (A.E.J.), University of Pittsburgh, and the Center for Health Equity Research and Promotion, Veterans Affairs Pittsburgh Healthcare System (W.F.G.) - both in Pittsburgh.

PMID: 29365283
DOI: 10.1056/NEJMp1716139

No abstract available

MeSH terms

Drug Costs*
Economics, Hospital*
Hospitals
Medicare Part B / economics*
Poverty*
Reimbursement Mechanisms*
United States